Life Technologies (LIFE) Acquires Compendia Bioscience
10/8/2012 10:45:44 AM
More...
|
Compendia Bioscience Release: Oncomine Contributes to Integrative Genomic Analysis of Lethal Castration-Resistant Prostate Cancer
5/22/2012 10:19:13 AM
More...
|
Compendia Bioscience and H3 Biomedicine Inc. Announce Strategic Collaboration to Apply Cancer Genomics to Discover and Develop Next Generation Cancer Therapeutics
2/14/2012 11:39:20 AM
More...
|
Compendia Bioscience and Althea Diagnostics Develop Breast Cancer Segregation Panel(TM) Assay as a Platform for Companion Diagnostic Development
12/9/2010 7:27:05 AM
More...
|
AltheaDx and Compendia Bioscience Launch the Breast Cancer Segregation Panel(TM)
12/9/2010 6:53:45 AM
More...
|
Compendia Bioscience and Althea Diagnostics Develop Breast Cancer Segregation Panel(TM) Assay as a Platform for Companion Diagnostic Development
12/8/2010 12:37:44 PM
More...
|
Compendia Bioscience Awarded $1.3 Million in SBIR Fast Track Funds
8/31/2010 10:09:38 AM
More...
|
Compendia Bioscience Awarded $1.3 Million in SBIR Fast Track Funds
8/31/2010 9:05:49 AM
More...
|
Compendia Bioscience Announces Collaboration with MDS Pharma Services (MDZ) to Deliver Novel Solution for Oncology Drug Development
4/29/2009 11:41:23 AM
More...
|
MDS Pharma Services (MDZ) Announces Collaboration with Compendia Bioscience to Deliver Novel Solution for Oncology Drug Development
4/28/2009 8:15:24 AM
More...
|
|